[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Drug-Eluting Balloons Market Report 2017

November 2017 | 100 pages | ID: UA51B5EB47DWEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Drug-Eluting Balloons market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Drug-Eluting Balloons in these regions, from 2012 to 2022 (forecast).
United States Drug-Eluting Balloons market competition by top manufacturers/players, with Drug-Eluting Balloons sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Boston Scientific
  • Medtronic
  • Cook Medical
  • C.R. Bard
  • B. Braun
  • Eurocor GmbH
  • Blue Medical
  • Bayer
  • Aachen Resonance
  • Acrostak
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Semi-Compliant Balloons
  • Non-Compliant Balloons
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Treatment of In-stent Restenosis (ISR)
  • Treatment of Small Vessel Disease (SVD)
  • Treatment of Bifurcation Stenoses
  • Treatment of Primary Coronary Artery Disease
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Drug-Eluting Balloons Market Report 2017

1 DRUG-ELUTING BALLOONS OVERVIEW

1.1 Product Overview and Scope of Drug-Eluting Balloons
1.2 Classification of Drug-Eluting Balloons by Product Category
  1.2.1 United States Drug-Eluting Balloons Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Drug-Eluting Balloons Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Semi-Compliant Balloons
  1.2.4 Non-Compliant Balloons
1.3 United States Drug-Eluting Balloons Market by Application/End Users
  1.3.1 United States Drug-Eluting Balloons Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Treatment of In-stent Restenosis (ISR)
  1.3.3 Treatment of Small Vessel Disease (SVD)
  1.3.4 Treatment of Bifurcation Stenoses
  1.3.5 Treatment of Primary Coronary Artery Disease
1.4 United States Drug-Eluting Balloons Market by Region
  1.4.1 United States Drug-Eluting Balloons Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Drug-Eluting Balloons Status and Prospect (2012-2022)
  1.4.3 Southwest Drug-Eluting Balloons Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Drug-Eluting Balloons Status and Prospect (2012-2022)
  1.4.5 New England Drug-Eluting Balloons Status and Prospect (2012-2022)
  1.4.6 The South Drug-Eluting Balloons Status and Prospect (2012-2022)
  1.4.7 The Midwest Drug-Eluting Balloons Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Drug-Eluting Balloons (2012-2022)
  1.5.1 United States Drug-Eluting Balloons Sales and Growth Rate (2012-2022)
  1.5.2 United States Drug-Eluting Balloons Revenue and Growth Rate (2012-2022)

2 UNITED STATES DRUG-ELUTING BALLOONS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Drug-Eluting Balloons Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Drug-Eluting Balloons Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Drug-Eluting Balloons Average Price by Players/Suppliers (2012-2017)
2.4 United States Drug-Eluting Balloons Market Competitive Situation and Trends
  2.4.1 United States Drug-Eluting Balloons Market Concentration Rate
  2.4.2 United States Drug-Eluting Balloons Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Drug-Eluting Balloons Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DRUG-ELUTING BALLOONS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Drug-Eluting Balloons Sales and Market Share by Region (2012-2017)
3.2 United States Drug-Eluting Balloons Revenue and Market Share by Region (2012-2017)
3.3 United States Drug-Eluting Balloons Price by Region (2012-2017)

4 UNITED STATES DRUG-ELUTING BALLOONS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Drug-Eluting Balloons Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Drug-Eluting Balloons Revenue and Market Share by Type (2012-2017)
4.3 United States Drug-Eluting Balloons Price by Type (2012-2017)
4.4 United States Drug-Eluting Balloons Sales Growth Rate by Type (2012-2017)

5 UNITED STATES DRUG-ELUTING BALLOONS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Drug-Eluting Balloons Sales and Market Share by Application (2012-2017)
5.2 United States Drug-Eluting Balloons Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES DRUG-ELUTING BALLOONS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Boston Scientific
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Drug-Eluting Balloons Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Boston Scientific Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Medtronic
  6.2.2 Drug-Eluting Balloons Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Medtronic Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Cook Medical
  6.3.2 Drug-Eluting Balloons Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Cook Medical Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 C.R. Bard
  6.4.2 Drug-Eluting Balloons Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 C.R. Bard Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 B. Braun
  6.5.2 Drug-Eluting Balloons Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 B. Braun Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Eurocor GmbH
  6.6.2 Drug-Eluting Balloons Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Eurocor GmbH Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Blue Medical
  6.7.2 Drug-Eluting Balloons Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Blue Medical Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bayer
  6.8.2 Drug-Eluting Balloons Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bayer Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Aachen Resonance
  6.9.2 Drug-Eluting Balloons Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Aachen Resonance Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Acrostak
  6.10.2 Drug-Eluting Balloons Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Acrostak Drug-Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 DRUG-ELUTING BALLOONS MANUFACTURING COST ANALYSIS

7.1 Drug-Eluting Balloons Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drug-Eluting Balloons

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Drug-Eluting Balloons Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drug-Eluting Balloons Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DRUG-ELUTING BALLOONS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Drug-Eluting Balloons Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Drug-Eluting Balloons Sales Volume Forecast by Type (2017-2022)
11.3 United States Drug-Eluting Balloons Sales Volume Forecast by Application (2017-2022)
11.4 United States Drug-Eluting Balloons Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Drug-Eluting Balloons
Figure United States Drug-Eluting Balloons Market Size (K Units) by Type (2012-2022)
Figure United States Drug-Eluting Balloons Sales Volume Market Share by Type (Product Category) in 2016
Figure Semi-Compliant Balloons Product Picture
Figure Non-Compliant Balloons Product Picture
Figure United States Drug-Eluting Balloons Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Drug-Eluting Balloons by Application in 2016
Figure Treatment of In-stent Restenosis (ISR) Examples
Table Key Downstream Customer in Treatment of In-stent Restenosis (ISR)
Figure Treatment of Small Vessel Disease (SVD) Examples
Table Key Downstream Customer in Treatment of Small Vessel Disease (SVD)
Figure Treatment of Bifurcation Stenoses Examples
Table Key Downstream Customer in Treatment of Bifurcation Stenoses
Figure Treatment of Primary Coronary Artery Disease Examples
Table Key Downstream Customer in Treatment of Primary Coronary Artery Disease
Figure United States Drug-Eluting Balloons Market Size (Million USD) by Region (2012-2022)
Figure The West Drug-Eluting Balloons Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Drug-Eluting Balloons Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Drug-Eluting Balloons Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Drug-Eluting Balloons Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Drug-Eluting Balloons Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Drug-Eluting Balloons Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Drug-Eluting Balloons Sales (K Units) and Growth Rate (2012-2022)
Figure United States Drug-Eluting Balloons Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Drug-Eluting Balloons Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Drug-Eluting Balloons Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Drug-Eluting Balloons Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Drug-Eluting Balloons Sales Share by Players/Suppliers
Figure 2017 United States Drug-Eluting Balloons Sales Share by Players/Suppliers
Figure United States Drug-Eluting Balloons Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Drug-Eluting Balloons Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Drug-Eluting Balloons Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Drug-Eluting Balloons Revenue Share by Players/Suppliers
Figure 2017 United States Drug-Eluting Balloons Revenue Share by Players/Suppliers
Table United States Market Drug-Eluting Balloons Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Drug-Eluting Balloons Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Drug-Eluting Balloons Market Share of Top 3 Players/Suppliers
Figure United States Drug-Eluting Balloons Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Drug-Eluting Balloons Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Drug-Eluting Balloons Product Category
Table United States Drug-Eluting Balloons Sales (K Units) by Region (2012-2017)
Table United States Drug-Eluting Balloons Sales Share by Region (2012-2017)
Figure United States Drug-Eluting Balloons Sales Share by Region (2012-2017)
Figure United States Drug-Eluting Balloons Sales Market Share by Region in 2016
Table United States Drug-Eluting Balloons Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Drug-Eluting Balloons Revenue Share by Region (2012-2017)
Figure United States Drug-Eluting Balloons Revenue Market Share by Region (2012-2017)
Figure United States Drug-Eluting Balloons Revenue Market Share by Region in 2016
Table United States Drug-Eluting Balloons Price (USD/Unit) by Region (2012-2017)
Table United States Drug-Eluting Balloons Sales (K Units) by Type (2012-2017)
Table United States Drug-Eluting Balloons Sales Share by Type (2012-2017)
Figure United States Drug-Eluting Balloons Sales Share by Type (2012-2017)
Figure United States Drug-Eluting Balloons Sales Market Share by Type in 2016
Table United States Drug-Eluting Balloons Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Drug-Eluting Balloons Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drug-Eluting Balloons by Type (2012-2017)
Figure Revenue Market Share of Drug-Eluting Balloons by Type in 2016
Table United States Drug-Eluting Balloons Price (USD/Unit) by Types (2012-2017)
Figure United States Drug-Eluting Balloons Sales Growth Rate by Type (2012-2017)
Table United States Drug-Eluting Balloons Sales (K Units) by Application (2012-2017)
Table United States Drug-Eluting Balloons Sales Market Share by Application (2012-2017)
Figure United States Drug-Eluting Balloons Sales Market Share by Application (2012-2017)
Figure United States Drug-Eluting Balloons Sales Market Share by Application in 2016
Table United States Drug-Eluting Balloons Sales Growth Rate by Application (2012-2017)
Figure United States Drug-Eluting Balloons Sales Growth Rate by Application (2012-2017)
Table Boston Scientific Basic Information List
Table Boston Scientific Drug-Eluting Balloons Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boston Scientific Drug-Eluting Balloons Sales Growth Rate (2012-2017)
Figure Boston Scientific Drug-Eluting Balloons Sales Market Share in United States (2012-2017)
Figure Boston Scientific Drug-Eluting Balloons Revenue Market Share in United States (2012-2017)
Table Medtronic Basic Information List
Table Medtronic Drug-Eluting Balloons Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medtronic Drug-Eluting Balloons Sales Growth Rate (2012-2017)
Figure Medtronic Drug-Eluting Balloons Sales Market Share in United States (2012-2017)
Figure Medtronic Drug-Eluting Balloons Revenue Market Share in United States (2012-2017)
Table Cook Medical Basic Information List
Table Cook Medical Drug-Eluting Balloons Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cook Medical Drug-Eluting Balloons Sales Growth Rate (2012-2017)
Figure Cook Medical Drug-Eluting Balloons Sales Market Share in United States (2012-2017)
Figure Cook Medical Drug-Eluting Balloons Revenue Market Share in United States (2012-2017)
Table C.R. Bard Basic Information List
Table C.R. Bard Drug-Eluting Balloons Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure C.R. Bard Drug-Eluting Balloons Sales Growth Rate (2012-2017)
Figure C.R. Bard Drug-Eluting Balloons Sales Market Share in United States (2012-2017)
Figure C.R. Bard Drug-Eluting Balloons Revenue Market Share in United States (2012-2017)
Table B. Braun Basic Information List
Table B. Braun Drug-Eluting Balloons Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure B. Braun Drug-Eluting Balloons Sales Growth Rate (2012-2017)
Figure B. Braun Drug-Eluting Balloons Sales Market Share in United States (2012-2017)
Figure B. Braun Drug-Eluting Balloons Revenue Market Share in United States (2012-2017)
Table Eurocor GmbH Basic Information List
Table Eurocor GmbH Drug-Eluting Balloons Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eurocor GmbH Drug-Eluting Balloons Sales Growth Rate (2012-2017)
Figure Eurocor GmbH Drug-Eluting Balloons Sales Market Share in United States (2012-2017)
Figure Eurocor GmbH Drug-Eluting Balloons Revenue Market Share in United States (2012-2017)
Table Blue Medical Basic Information List
Table Blue Medical Drug-Eluting Balloons Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Blue Medical Drug-Eluting Balloons Sales Growth Rate (2012-2017)
Figure Blue Medical Drug-Eluting Balloons Sales Market Share in United States (2012-2017)
Figure Blue Medical Drug-Eluting Balloons Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Drug-Eluting Balloons Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Drug-Eluting Balloons Sales Growth Rate (2012-2017)
Figure Bayer Drug-Eluting Balloons Sales Market Share in United States (2012-2017)
Figure Bayer Drug-Eluting Balloons Revenue Market Share in United States (2012-2017)
Table Aachen Resonance Basic Information List
Table Aachen Resonance Drug-Eluting Balloons Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aachen Resonance Drug-Eluting Balloons Sales Growth Rate (2012-2017)
Figure Aachen Resonance Drug-Eluting Balloons Sales Market Share in United States (2012-2017)
Figure Aachen Resonance Drug-Eluting Balloons Revenue Market Share in United States (2012-2017)
Table Acrostak Basic Information List
Table Acrostak Drug-Eluting Balloons Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Acrostak Drug-Eluting Balloons Sales Growth Rate (2012-2017)
Figure Acrostak Drug-Eluting Balloons Sales Market Share in United States (2012-2017)
Figure Acrostak Drug-Eluting Balloons Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drug-Eluting Balloons
Figure Manufacturing Process Analysis of Drug-Eluting Balloons
Figure Drug-Eluting Balloons Industrial Chain Analysis
Table Raw Materials Sources of Drug-Eluting Balloons Major Players/Suppliers in 2016
Table Major Buyers of Drug-Eluting Balloons
Table Distributors/Traders List
Figure United States Drug-Eluting Balloons Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Drug-Eluting Balloons Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Drug-Eluting Balloons Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Drug-Eluting Balloons Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Drug-Eluting Balloons Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Drug-Eluting Balloons Sales Volume (K Units) Forecast by Type in 2022
Table United States Drug-Eluting Balloons Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Drug-Eluting Balloons Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Drug-Eluting Balloons Sales Volume (K Units) Forecast by Application in 2022
Table United States Drug-Eluting Balloons Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Drug-Eluting Balloons Sales Volume Share Forecast by Region (2017-2022)
Figure United States Drug-Eluting Balloons Sales Volume Share Forecast by Region (2017-2022)
Figure United States Drug-Eluting Balloons Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories